Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the future of the artificial pancreas.
Read More »Bruce Bode Part 1, Artificial Pancreas
Bruce Bode Part 2, Artificial Pancreas Safety
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the focus on safety during the trial.
Read More »Bruce Bode Part 3, Customizing the Artificial Pancreas
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about what's next in the efforts to perfect the artificial pancreas.
Read More »Bruce Bode Part 4, Ideal Candidates for the Artificial Pancreas
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the impact of the artificial pancreas on parents of children with type 1 diabetes.
Read More »Bruce Bode Part 5, Development of the Artificial Pancreas
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about his first thoughts about pump technology.
Read More »Bruce Bode Part 6, Continuous Glucose Monitoring (CGM) Devices
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the future of CGMs.
Read More »Bruce Bode Part 7, CGM Impact on Diabetes Treatment
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about his work with type 2 diabetes patients.
Read More »Ahmad Yehya Full Interview
In this Exclusive Interview, Dr. Yehya explains the benefits of bariatric surgery in specific patient populations.
Read More »Ahmad Yehya Transcript
Dr. Ahmad Yehya discusses the benefits of bariatric surgery and how studies have shown it improves outcomes in certain patient populations, specifically patients with BMI between 35 and 40.
Read More »Current Interview: Dr. Steven Edelman
Dr. Steven Edelman, MD, brings his research on the topic of adherence and persistence in type 2 medications.
Read More »